The reintroduction of SMAD4 was confirmed by western blot (Figure 4C) using Panc-1, a pancreatic cancer cell line with no mutation or loss of the SMAD4 genetic locus, as a control reference. This evidence concerns the gene SMAD4 and familial pancreatic carcinoma.